Finzati - Logo
ATR logo

AptarGroup, Inc.

ATR • Medical - Instruments & Supplies
$127.41
▼ -0.90 (-0.70%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$8.22B
Growth
7.3%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 10.4%Positive free cash flow · 4.56Consistent free cash flow · 5/5Reasonable earnings multiple · 20.41Manageable debt level · 0.57
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$127.41
Change-0.70%
Shares Out64.50M
Market Cap$8.22B
Enterprise Value$9.14B
52W Range103.23 - 158.12
Beta0.39
P/E22.67
P/S2.09
P/B296.46
P/FCF25.33
EV/Sales2.32

Investment DNA

How strong this company looks for long-term investors

78
out of 100
Business Quality
Margins, moat, returns
71/100
Financial Strength
Debt, cash, stability
82/100
Growth Potential
Revenue and expansion
77/100
Price Attractiveness
Cheap or expensive today
73/100
Why this score▼
Stable or improving margins · 10.4%Positive free cash flow · 4.56Consistent free cash flow · 5/5Reasonable earnings multiple · 20.41Manageable debt level · 0.57Healthy liquidity · 1.62

Analyst view

Analyst sentiment and price target

ATR
Analyst sentiment
Based on 18 analyst votes · 2026-09-05
64/100
Neutral
Bullish
8
Hold
7
Bearish
3
Price Target
2026-07-31
Low
$156.00
Mean
$158.00
Median
$158.00
High
$160.00

Company Overview

IPO: 4/23/1993
Industry: Medical - Instruments & Supplies
P/B i: 296.46
Debt / Equity i: 0.57
Operating Margin: 13.56%
Net Margin: 10.40%
ROE i: -
ROIC: -

Financial Health

Score16 / 20
Debt / Equity: 0.57
Current Ratio: 1.62
Quick Ratio: 1.16
Status: Strong

Insider Transactions

Recent executive and insider activity

Trerotola Matthew L.
Transaction: 07/16/2026
BUY
Change
+151
Price
Not reported
Filing
07/17/2026
Type
BUY
Xing Julie
Transaction: 07/16/2026
BUY
Change
+151
Price
Not reported
Filing
07/17/2026
Type
BUY
Glickman Sarah JS
Transaction: 07/16/2026
BUY
Change
+151
Price
Not reported
Filing
07/17/2026
Type
BUY